Clinical Trial Update: Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized pilot trial comparing tamoxifen to estradiol for unscheduled vaginal bleeding in etonogestrel implant users was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Bleeding

Drugs mentioned

• ESTRADIOL (Estradiol)
• Etonogestrel implant (etonogestrel)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Vaginal Bleeding | Phase 4 | Status: WITHDRAWN